Application of peptide receptor radionuclide therapy for gastroenteropancreatic neuroendocrine tumor / 中华消化外科杂志
Chinese Journal of Digestive Surgery
;
(12): 763-766, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-699196
ABSTRACT
Peptide receptor radionuclide therapy (PRRT),being investigated as an effective treatment for inoperable gastroenteropancreatic neuroendocrine tumor,has gained much importance in recent years.With increasing data of clinical trials and the exploration of different radionuclides as well as the toxic and side effects,PRRT has developed continuously and play a marked role on the treatment of gastroenteropancreatic neuroendocrine tumor.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Digestive Surgery
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS